2012
DOI: 10.1016/j.bpobgyn.2011.11.007
|View full text |Cite
|
Sign up to set email alerts
|

Breast cancer screening in developing countries

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
43
0
3

Year Published

2012
2012
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 58 publications
(46 citation statements)
references
References 7 publications
0
43
0
3
Order By: Relevance
“…BSE alone did not show a decrease in mortality or down-staging of advanced cancer in earlier clinical trials, but is expected to increase breast cancer awareness and might help to decrease tumour size and stage at diagnosis in settings where women mainly present with late stages (Garg et al, 2010;Mittra, 2011;Corbex et al, 2012;Panieri, 2012).…”
Section: Introductionmentioning
confidence: 89%
“…BSE alone did not show a decrease in mortality or down-staging of advanced cancer in earlier clinical trials, but is expected to increase breast cancer awareness and might help to decrease tumour size and stage at diagnosis in settings where women mainly present with late stages (Garg et al, 2010;Mittra, 2011;Corbex et al, 2012;Panieri, 2012).…”
Section: Introductionmentioning
confidence: 89%
“…Ghazali et al stated that females who never practice BSE in their lives were more likely to be diagnosed with the delay of BC compared to those who regularly implemented BSE (Ghazali et al, 2013). It may lead to increase the BC awareness and might lessen the malignancy stage at admission period in a location where women especially could not take advantage of early diagnostic methods including clinical breast examination, mammography, and ultrasonography (Parvani, 2011;Corbex et al, 2012;Panieri, 2012). Moreover, BSE is a non-invasive intervention carried out by females themselves without any support of medical health-care providers.…”
Section: Introductionmentioning
confidence: 99%
“…El autoexamen de mama (AEM) es un método de evaluación continua que, de ser efectivo, podría ser simple y barato. Si este es el caso, permitiría que el diagnóstico sea temprano y que la mortalidad se reduzca en países en desarrollo (4,5), particularmente en contextos que carecen de acceso a tecnologías modernas y especializadas. Se sugiere que el AEM puede reducir la mortalidad por cáncer de mama en países donde el diagnóstico suele darse en estadios avanzados (4).…”
Section: Introductionunclassified